Keros Therapeutics
KROS
KROS
150 hedge funds and large institutions have $206M invested in Keros Therapeutics in 2026 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 47 increasing their positions, 55 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
50% less capital invested
Capital invested by funds: $409M → $206M (-$203M)
55% less call options, than puts
Call options by funds: $1.37M | Put options by funds: $3.05M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
150
Holding in Top 10
–
Calls
$1.37M
Puts
$3.05M
Top Buyers
| 1 | +$15.4M | |
| 2 | +$4.07M | |
| 3 | +$3.49M | |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$3.07M |
| 5 |
EF
Empowered Funds
Havertown,
Pennsylvania
|
+$2.25M |
Top Sellers
| 1 | -$11.5M | |
| 2 | -$7.94M | |
| 3 | -$5.65M | |
| 4 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
-$5.17M |
| 5 |
AG
Algert Global
San Francisco,
California
|
-$3.94M |
